You are here

Pharma CEOs

CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess

CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess

Endpoints

Vasant Narasimham

Flag link:

Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts

Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts

Fierce Pharma

Flag link:

GSK chief Emma Walmsley rounds out her top team with CFO pick — but performance lags

GSK chief Emma Walmsley rounds out her top team with CFO pick — but performance lags

Endpoints

Flag link:

Pfizer CEO predicts that controversial rebates are ‘going away’

Pfizer CEO predicts that controversial rebates are ‘going away’

Stat

Flag link:

Is Gilead Sciences' Sudden Change in Leadership a Good Thing?

Is Gilead Sciences' Sudden Change in Leadership a Good Thing?

Motley Fool

Gilead Sciences

Flag link:

Gilead CEO John Milligan Stepping Down as Head of Biotech Giant

Gilead CEO John Milligan Stepping Down as Head of Biotech Giant

Bloomberg

Gilead Sciences

Flag link:

Pfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For The U.S. Economy

Pfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For The U.S. Economy

Forbes

pharma industry

Flag link:

AngioDynamics CEO Clemmer is on the M&A trail

AngioDynamics CEO Clemmer is on the M&A trail

Mass Device

Flag link:

Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump

Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump

Fierce Pharma

Flag link:

Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest

Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest

Endpoints

Flag link:

Sanofi’s Andre Turenne Is Slated to Become Voyager Therapeutics CEO

Sanofi’s Andre Turenne Is Slated to Become Voyager Therapeutics CEO

Xconomy

Voyager Therapeutics

Flag link:

Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post

Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post

Xconomy

Deborah Dunsire

Flag link:

Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi

Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi

Fierce Pharma

Sprout Pharmaceuticals

Cindy Whitehead

Flag link:

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Endpoints

Flag link:

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Flag link:

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Xconomy

Portola Pharmaceuticals

Flag link:

Takeda CEO Sees Path to Survival in Shire Megadeal

Takeda CEO Sees Path to Survival in Shire Megadeal

Bloomberg

Flag link:

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million

Forbes

Flag link:

Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Endpoints

Flag link:

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

BioSpace

Akari Therapeutics

David Horn Solomon

Flag link:

Pages